Literature DB >> 19491338

No evidence for association between TGFB1 promoter SNPs and the risk of childhood pre-B acute lymphoblastic leukemia among French Canadians.

Jasmine Healy, Marie-Helene Roy-Gagnon, Daniel Sinnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19491338      PMCID： PMC2704319          DOI： 10.3324/haematol.2009.005991

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay.

Authors:  D Labuda; M Krajinovic; C Richer; A Skoll; H Sinnett; V Yotova; D Sinnett
Journal:  Anal Biochem       Date:  1999-11-01       Impact factor: 3.365

2.  A powerful strategy to account for multiple testing in the context of haplotype analysis.

Authors:  Tim Becker; Michael Knapp
Journal:  Am J Hum Genet       Date:  2004-07-30       Impact factor: 11.025

3.  Detection and characterization of DNA variants in the promoter regions of hundreds of human disease candidate genes.

Authors:  Daniel Sinnett; Patrick Beaulieu; Hélène Bélanger; Jean-François Lefebvre; Sylvie Langlois; Marie-Christine Théberge; Simon Drouin; Corinne Zotti; Thomas J Hudson; Damian Labuda
Journal:  Genomics       Date:  2006-02-24       Impact factor: 5.736

Review 4.  Role of transforming growth factor Beta in human cancer.

Authors:  Rebecca L Elliott; Gerard C Blobe
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

5.  Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia.

Authors:  Jasmine Healy; Hélène Bélanger; Patrick Beaulieu; Mathieu Larivière; Damian Labuda; Daniel Sinnett
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

6.  Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia.

Authors:  Barbara S Saltzman; Jennifer F Yamamoto; Robert Decker; Lance Yokochi; Andre G Theriault; Thomas M Vogt; Loïc Le Marchand
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

7.  Polymorphisms in TGF-beta1 gene and the risk of lung cancer.

Authors:  Hyo-Gyoung Kang; Myung Hwa Chae; Jung Min Park; Eun Jin Kim; Jae Hyung Park; Sin Kam; Sung Ick Cha; Chang Ho Kim; Rang-Woon Park; Sun Hee Park; Yong Lim Kim; In-San Kim; Tae Hoon Jung; Jae Yong Park
Journal:  Lung Cancer       Date:  2006-02-24       Impact factor: 5.705

8.  A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.

Authors:  Alison M Dunning; Peter D Ellis; Simon McBride; Heidi L Kirschenlohr; Catherine S Healey; Paul R Kemp; Robert N Luben; Jenny Chang-Claude; Arto Mannermaa; Vesa Kataja; Paul D P Pharoah; Douglas F Easton; Bruce A J Ponder; James C Metcalfe
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

9.  Maximum-likelihood estimation of haplotype frequencies in nuclear families.

Authors:  Tim Becker; Michael Knapp
Journal:  Genet Epidemiol       Date:  2004-07       Impact factor: 2.135

10.  A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.

Authors:  Amanda Ewart-Toland; June M Chan; Jinwei Yuan; Allan Balmain; Jing Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-05       Impact factor: 4.254
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.